US researchers conducted a trial of over 28,000 women aged 40-74 to find an effective way of distributing breast cancer screening resources. Results published in JAMA on 12 Dec.
Median & mean out-of-pocket expenditure are Rs 1,26,988 and Rs 1,86,461, respectively, find researchers at Tata Memorial Centre & International Institute for Population Sciences.
The study, published in American Cancer Society Journal, shows survival rate 5 yrs after diagnosis ranges from 41.9% in Pasighat to 74.9% in Mizoram. In countries like US, it's over 90%.
Breast cancer is one of the most commonly diagnosed cancers in India. Most existing Trastuzumab brands in Indian market are priced between Rs 40,000 and Rs 54,000 per 440 mg vial.
Is there a place for a counter-bureaucracy, or a separate and competing bureaucracy to counterbalance the force of the executive’s bureaucracy, asked author MH Mody in 1980.
With bad loans shrinking & capital buffers stronger, urban co-op banks’ new umbrella body NUCFDC is now prioritising rollout of digital transformation.
If deal goes through, Greece will be 2nd foreign country to procure vehicle. Morocco was first; TATA Group has set up manufacturing unit there with minimum 30 percent indigenous content.
Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.
COMMENTS